Soleno Therapeutics, Inc. (SLNO) financial statements (2021 and earlier)

Company profile

Business Address 1235 RADIO ROAD
REDWOOD CITY, CA 94065
State of Incorp. DE
Fiscal Year End December 31
SIC 3845 - Electromedical and Electrotherapeutic Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments212317358
Cash and cash equivalents212317358
Restricted cash and investments  0000
Receivables 0 00 
Inventory, net of allowances, customer advances and progress billings   110
Inventory   110
Other undisclosed current assets021000
Total current assets:212518468
Noncurrent Assets
Finance lease, right-of-use asset0
Operating lease, right-of-use asset0
Property, plant and equipment000000
Intangible assets, net (including goodwill)17182011 
Goodwill   11 
Intangible assets, net (excluding goodwill)17182000 
Other noncurrent assets0 011 
Other undisclosed noncurrent assets  0   
Total noncurrent assets:171821220
TOTAL ASSETS:384339688
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities211111
Accounts payable211111
Employee-related liabilities0     
Debt0    0
Derivative instruments and hedges, liabilities    1 
Disposal group, including discontinued operation  0   
Other liabilities0     
Other undisclosed current liabilities211120
Total current liabilities:522231
Noncurrent Liabilities
Long-term debt and lease obligation0     
Finance lease, liability0
Operating lease, liability0
Liabilities, other than long-term debt041000 
Deferred tax liabilities, net44   
Disposal group, including discontinued operation, liabilities  0   
Other liabilities0 000 
Business combination, contingent consideration, liability  5   
Other undisclosed noncurrent liabilities18710  
Total noncurrent liabilities:18111100 
Total liabilities:231312231
Stockholders' equity
Stockholders' equity attributable to parent, including:15302733(10)
Common stock000000
Additional paid in capital1731571401028961
Accumulated deficit(158)(127)(114)(98)(86)(71)
Other undisclosed stockholders' equity attributable to parent  000 
Total stockholders' equity:15302733(10)
Other undisclosed liabilities and equity    217
TOTAL LIABILITIES AND EQUITY:384339688

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues0  11 
Revenue, net 11 
Sublease income0
Cost of revenue   (2)(0) 
Gross profit:0  (0)0 
Operating expenses(23)(14)(12)(14)(12)(5)
Other operating expense, net
(Other Nonrecurring (Income) Expense)
  (1)   
Other undisclosed operating income (loss)(0) 1   
Operating loss:(23)(14)(12)(14)(12)(5)
Nonoperating income (expense)(7)2(2)2 (3)
Investment income, nonoperating 2   0
Debt instrument, convertible, beneficial conversion feature     2
Other nonoperating income (expense)0(0)(2)2 (5)
Interest and debt expense(0)   (3)(4)
Other undisclosed income from continuing operations before equity method investments, income taxes0 27   
Income (loss) from continuing operations before equity method investments, income taxes:(31)(12)14(12)(15)(12)
Loss from equity method investments(0)(0)    
Other undisclosed income (loss) from continuing operations before income taxes 0(27)   
Loss from continuing operations before income taxes:(31)(12)(14)(12)(15)(12)
Income tax expense (benefit)  2(0)  
Loss from continuing operations:(31)(12)(12)(12)(15)(12)
Loss from discontinued operations (1)(4)   
Loss before gain (loss) on sale of properties:(31)(13)(16)(12)(15)(12)
Other undisclosed net income0     
Net loss:(31)(13)(16)(12)(15)(12)
Other undisclosed net loss attributable to parent    (1)(2)
Net loss attributable to parent:(31)(13)(16)(12)(16)(14)
Preferred stock dividends and other adjustments   (4)(3) 
Net loss available to common stockholders, diluted:(31)(13)(16)(16)(19)(14)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(31)(13)(16)(12)(15)(12)
Comprehensive loss, net of tax, attributable to parent:(31)(13)(16)(12)(15)(12)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: